Xenopat
PrivateLast Round
Grant
Apr 27, 2025
Total Funding Raised
$245,000
Company Overview
Xenopat is a biotechnology company that provides R&D services based on orthoxenografts®, which are mouse models with implanted human tumors, for anticancer drug development and personalized cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xenopat Comparables
Compare Xenopat with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XenTech SAS | 87% | |
| Experimental Pharmacology & Oncology Berlin-Buch GmbH | 82% | |
| Pharmatest Services | 77% | |
Xenopat Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 27, 2025 | ||||
| Grant | Feb 22, 2018 |
Xenopat Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACCIÓ - Agency for Business Competitiveness | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Monthly visitors grew 134% MoM.
- Feb 22, 2018
$93K grant received from ACCIÓ.
Xenopat Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xenopat's valuation, stock price, and market status.